.png){kind=icon}
-
Rapid & Robust Preclinical & Clinical Development of CAR T-Cell Therapies
Case StudiesJul. 31, 2020
This case study distinguishes how Covance helped the sponsor identify lead assets, navigate through IND-submission and conduct Phase I/II dosing studies in an accelerated timeframe.
This case study distinguishes how Covance helped the sponsor identify lead assets, navigate through IND-submission and conduct Phase I/II dosing studies in an accelerated timeframe.
